Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir versus oseltamivir in adults aged 75 years and older with influenza
jRCTs071200034Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in influenza comparing Baloxavir group with Oseltamivir group (2 arms). Primary endpoint: Duration of influenza disease. Started Jan 2021; status: completed.
02
Drugs
baloxavir marboxiloseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCTs071200034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200034.